| UniProt ID | MED6_HUMAN | |
|---|---|---|
| UniProt AC | O75586 | |
| Protein Name | Mediator of RNA polymerase II transcription subunit 6 | |
| Gene Name | MED6 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 246 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.. | |
| Protein Sequence | MAAVDIRDNLLGISWVDSSWIPILNSGSVLDYFSERSNPFYDRTCNNEVVKMQRLTLEHLNQMVGIEYILLHAQEPILFIIRKQQRQSPAQVIPLADYYIIAGVIYQAPDLGSVINSRVLTAVHGIQSAFDEAMSYCRYHPSKGYWWHFKDHEEQDKVRPKAKRKEEPSSIFQRQRVDALLLDLRQKFPPKFVQLKPGEKPVPVDQTKKEAEPIPETVKPEEKETTKNVQQTVSAKGPPEKRMRLQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 44 | Phosphorylation | SNPFYDRTCNNEVVK CCCCCCCCCCHHHHH | 19.38 | 25332170 | |
| 51 | Ubiquitination | TCNNEVVKMQRLTLE CCCHHHHHHHHHCHH | 34.19 | - | |
| 51 | Ubiquitination | TCNNEVVKMQRLTLE CCCHHHHHHHHHCHH | 34.19 | - | |
| 136 | Phosphorylation | AFDEAMSYCRYHPSK HHHHHHHHHHCCCCC | 2.82 | - | |
| 139 | Phosphorylation | EAMSYCRYHPSKGYW HHHHHHHCCCCCCCE | 17.96 | - | |
| 143 | Ubiquitination | YCRYHPSKGYWWHFK HHHCCCCCCCEEEEC | 61.54 | - | |
| 145 | Phosphorylation | RYHPSKGYWWHFKDH HCCCCCCCEEEECCH | 14.73 | - | |
| 150 | Ubiquitination | KGYWWHFKDHEEQDK CCCEEEECCHHHHHC | 45.34 | - | |
| 157 | Ubiquitination | KDHEEQDKVRPKAKR CCHHHHHCCCCCHHC | 39.58 | - | |
| 164 (in isoform 3) | Phosphorylation | - | 57.38 | 22210691 | |
| 165 (in isoform 3) | Phosphorylation | - | 66.77 | 22210691 | |
| 165 | Ubiquitination | VRPKAKRKEEPSSIF CCCCHHCCCCCCHHH | 66.77 | 21906983 | |
| 167 (in isoform 3) | Phosphorylation | - | 54.22 | 22210691 | |
| 172 | Ubiquitination | KEEPSSIFQRQRVDA CCCCCHHHHHHHHHH | 5.45 | - | |
| 196 | Ubiquitination | PPKFVQLKPGEKPVP CCCCCCCCCCCCCCC | 33.61 | 21906983 | |
| 200 | Ubiquitination | VQLKPGEKPVPVDQT CCCCCCCCCCCCCCC | 58.17 | 21890473 | |
| 200 | Acetylation | VQLKPGEKPVPVDQT CCCCCCCCCCCCCCC | 58.17 | 25953088 | |
| 203 | Ubiquitination | KPGEKPVPVDQTKKE CCCCCCCCCCCCCCC | 32.28 | - | |
| 207 | Ubiquitination | KPVPVDQTKKEAEPI CCCCCCCCCCCCCCC | 39.35 | 21890473 | |
| 208 | Sumoylation | PVPVDQTKKEAEPIP CCCCCCCCCCCCCCC | 42.88 | 28112733 | |
| 216 | Ubiquitination | KEAEPIPETVKPEEK CCCCCCCCCCCHHHH | 67.94 | - | |
| 219 | Sumoylation | EPIPETVKPEEKETT CCCCCCCCHHHHHCC | 54.88 | - | |
| 219 | Sumoylation | EPIPETVKPEEKETT CCCCCCCCHHHHHCC | 54.88 | - | |
| 219 | Acetylation | EPIPETVKPEEKETT CCCCCCCCHHHHHCC | 54.88 | 26051181 | |
| 226 | Ubiquitination | KPEEKETTKNVQQTV CHHHHHCCCCHHHHH | 23.01 | - | |
| 227 | Ubiquitination | PEEKETTKNVQQTVS HHHHHCCCCHHHHHH | 63.64 | 21906983 | |
| 234 | Ubiquitination | KNVQQTVSAKGPPEK CCHHHHHHCCCCHHH | 27.87 | - | |
| 234 | Phosphorylation | KNVQQTVSAKGPPEK CCHHHHHHCCCCHHH | 27.87 | 25159151 | |
| 236 | Ubiquitination | VQQTVSAKGPPEKRM HHHHHHCCCCHHHHH | 65.53 | 19608861 | |
| 236 | Acetylation | VQQTVSAKGPPEKRM HHHHHHCCCCHHHHH | 65.53 | 19608861 | |
| 241 | Acetylation | SAKGPPEKRMRLQ-- HCCCCHHHHHCCC-- | 58.21 | 19608861 | |
| 243 | Ubiquitination | KGPPEKRMRLQ---- CCCHHHHHCCC---- | 8.10 | - | |
| 243 | Acetylation | KGPPEKRMRLQ---- CCCHHHHHCCC---- | 8.10 | - | |
| 243 | Acetylation | KGPPEKRMRLQ---- CCCHHHHHCCC---- | 8.10 | 19608861 | |
| 243 | Ubiquitination | KGPPEKRMRLQ---- CCCHHHHHCCC---- | 8.10 | 19608861 | |
| 248 | Acetylation | KRMRLQ--------- HHHCCC--------- | - | ||
| 248 | Acetylation | KRMRLQ--------- HHHCCC--------- | 19608861 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MED6_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MED6_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MED6_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MED15_HUMAN | MED15 | physical | 14983011 | |
| CDK8_HUMAN | CDK8 | physical | 14983011 | |
| MED14_HUMAN | MED14 | physical | 9734358 | |
| MED21_HUMAN | MED21 | physical | 9734358 | |
| CUL1_HUMAN | CUL1 | physical | 22479149 | |
| MED7_HUMAN | MED7 | physical | 22939629 | |
| MED23_HUMAN | MED23 | physical | 10993082 | |
| CCNC_HUMAN | CCNC | physical | 10993082 | |
| MED10_HUMAN | MED10 | physical | 10993082 | |
| MED10_HUMAN | MED10 | physical | 26344197 | |
| MED11_HUMAN | MED11 | physical | 26344197 | |
| MED12_HUMAN | MED12 | physical | 26344197 | |
| MED14_HUMAN | MED14 | physical | 26344197 | |
| MED15_HUMAN | MED15 | physical | 26344197 | |
| MED16_HUMAN | MED16 | physical | 26344197 | |
| MED17_HUMAN | MED17 | physical | 26344197 | |
| MED18_HUMAN | MED18 | physical | 26344197 | |
| MED19_HUMAN | MED19 | physical | 26344197 | |
| MED24_HUMAN | MED24 | physical | 26344197 | |
| MED27_HUMAN | MED27 | physical | 26344197 | |
| MED4_HUMAN | MED4 | physical | 26344197 | |
| MED8_HUMAN | MED8 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-236 AND LYS-241, AND MASSSPECTROMETRY. | |